Cunte Chen
Impact in
-
- Cancer-related molecular mechanisms research
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Oncology 15
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 7
- Co-authors
- Yangqiu Li (33 shared papers)Chengwu Zeng (20 shared papers)Shunqing Wang (11 shared papers)Yuping Zhang (10 shared papers)Peipei Wang (5 shared papers)Shaohua Chen (7 shared papers)Xibao Yu (5 shared papers)Wenjian Mo (8 shared papers)
- Journals
- Biomarker Research (3 papers)Journal of Oncology (2 papers)European Journal of Pharmacology (2 papers)Cancer Medicine (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaMontenegroUnited States
In The Last Decade
Cunte Chen
49 papers receiving 548 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 102
- Hematology 76
- Oncology 173
- Immunology 110
- Pulmonary and Respiratory Medicine 84
Countries citing papers authored by Cunte Chen
This map shows the geographic impact of Cunte Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunte Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunte Chen more than expected).
Fields of papers citing papers by Cunte Chen
This network shows the impact of papers produced by Cunte Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunte Chen. The network helps show where Cunte Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Cunte Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 48 | |
| 2 | 2022 | 44 | |
| 3 | 2022 | 31 | |
| 4 | 2021 | 29 | |
| 5 | 2021 | 28 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 27 | |
| 8 | 2022 | 26 | |
| 9 | 2024 | 26 | |
| 10 | 2021 | 25 | |
| 11 | Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial | 2022 | 20 |
| 12 | 2021 | 15 | |
| 13 | 2020 | 14 | |
| 14 | 2024 | 13 | |
| 15 | 2023 | 13 | |
| 16 | 2020 | 12 | |
| 17 | 2023 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2023 | 9 |
About Cunte Chen
Cunte Chen is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Immunology, having authored 50 papers that have together received 549 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (7 papers), Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers), Immune Cell Function and Interaction (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (102 citations), Hematology (76 citations), Oncology (173 citations), Immunology (110 citations) and Pulmonary and Respiratory Medicine (84 citations). Cunte Chen has collaborated with scholars based in China, Montenegro and United States. Frequent co-authors include Yangqiu Li, Chengwu Zeng, Shunqing Wang, Yuping Zhang, Peipei Wang, Shaohua Chen, Xibao Yu, Wenjian Mo, Xin Liu and Yong Wu. Their work appears in journals such as Biomarker Research, Journal of Oncology, European Journal of Pharmacology, Cancer Medicine and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.